Lots smallcap Biotech issues are on the verge of break-out upwards, e.g. ADLS DCGN CTIC PARD GNBT CEGE DSCO KERX ANPI INO ANDS IMMU, just to name a few... Many of them have retreated for many sessions and are coiled near the end of triangle patterns on a rising channel, a thrust rally could be happening any time from here...
My only concern is that the broad market may pill back next week to sink all boats.
My wishful thinking is that a sector rotation may step in to prevent the correction from a sharp drop. If you look at BTK daily chart, the Friday closing is right at its EMA5 which was served as a support line in the last 2 weeks during the quick run-up of the index. So it's hard to see the line being breached without a fight.
As long as a risk control is taken in place, the winning chance of going long with these biotechs is pretty high.
JMHO/YMYD
 |